Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalemia or High Risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry

This publication has 27 references indexed in Scilit:

• Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry
  Journal of Cardiac Failure, 2022
• Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors Over Time in Heart Failure with Reduced Ejection Fraction
  Journal of Cardiac Failure, 2022
• Abnormalities of Potassium in Heart Failure
  JACC, 2020
• Patiromer Versus Placebo to Enable Spironolactone Use in Patients with Resistant Hypertension and Chronic Kidney Disease ( AMBER ): Results in the Pre-Specified Subgroup with Heart Failure
  European Journal of Heart Failure, 2020
• Unravelling the Interplay Between Hyperkalaemia, Renin–Angiotensin–Aldosterone Inhibitor Use and Clinical Outcomes. Data from 9222 Chronic Heart Failure Patients of the ESC-HFA-EORP Heart Failure Long-Term Registry
  European Journal of Heart Failure, 2020
• Reasons for Lack of Improvement in Treatment With Evidence-Based Therapies in Heart Failure
  JACC, 2019
• Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
  JACC, 2019
• Medical Therapy for Heart Failure With Reduced Ejection Fraction
  JACC, 2018
• Chronic Exposure to Ivabradine Reduces Readmissions in the Vulnerable Phase After Hospitalization for Worsening Systolic Heart Failure: A Post-Hoc Analysis of SHIFT
  European Journal of Heart Failure, 2016
• Physicians’ Adherence to Guideline-Recommended Medications in Heart Failure with Reduced Ejection Fraction: Data from the QUALIFY Global Survey
  European Journal of Heart Failure, 2016